help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuruta, T.
Right arrow Articles by Kambara, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuruta, T.
Right arrow Articles by Kambara, T.

American Journal of Pathology, Vol 142, 1848-1857, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis

T Tsuruta, T Yamamoto, S Matsubara, S Nagasawa, S Tanase, J Tanaka, K Takagi and T Kambara
Division of Molecular Pathology, Graduate School of Medical Sciences, Kumamoto University, Japan.

The complement C4-derived anaphylatoxin, C4a, possesses a strong chemotaxis inhibitory capacity to blood monocytes at concentrations as low as 10(-16) mol/L. In our study, treatment with carboxypeptidase B to convert it to C4a des Arg77 decreased the inhibitory activity to less than 1/1,000. The extraordinary inhibitory capacity of C4a suggests the presence of an amplification mechanism in this inhibition. Indeed, we found that the conditioned media of peripheral blood mononuclear cells or monocyte/macrophage lineage cell lines (U937 and THP-1 cells) preincubated with 10(-16) mol/L C4a for 5 minutes or more at 37 C possessed the inhibitory capacity 100,000-fold stronger than the original activity of C4a. The monocyte-derived chemotaxis inhibitory factor seemed monocyte-specific. This cell-derived factor was sensitive to treatment with trypsin and chymotrypsin and immunologically distinct from C4a. The apparent molecular size of the monocyte factor was estimated to be approximately 20 kd by gel filtration. These results indicate that C4a anaphylatoxin induces the release from monocytes of a protein with inhibitory activity for monocyte chemotaxis.


This article has been cited by other articles:


Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. M. Marc, P. Korosec, M. Kosnik, I. Kern, M. Flezar, S. Suskovic, and J. Sorli
Complement Factors C3a, C4a, and C5a in Chronic Obstructive Pulmonary Disease and Asthma
Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 216 - 219.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Shrestha, M. Shiokawa, T. Nishimura, H. Nishiura, Y. Tanaka, N. Nishino, Y. Shibuya, and T. Yamamoto
Switch Moiety in Agonist/Antagonist Dual Effect of S19 Ribosomal Protein Dimer on Leukocyte Chemotactic C5a Receptor
Am. J. Pathol., April 1, 2003; 162(4): 1381 - 1388.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Lienenklaus, R. S. Ames, M. A. Tornetta, H. M. Sarau, J. J. Foley, T. Crass, B. Sohns, U. Raffetseder, M. Grove, A. Holzer, et al.
Cutting Edge: Human Anaphylatoxin C4a Is a Potent Agonist of the Guinea Pig But Not the Human C3a Receptor
J. Immunol., September 1, 1998; 161(5): 2089 - 2093.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Nishiura, Y. Shibuya, S. Matsubara, S. Tanase, T. Kambara, and T. Yamamoto
Monocyte Chemotactic Factor in Rheumatoid Arthritis Synovial Tissue
J. Biol. Chem., January 12, 1996; 271(2): 878 - 882.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Society for Investigative Pathology.